- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04899947
Child and Adolescent Registry for Participants With Narcolepsy
Children, Adolescents and Their Providers: the Narcolepsy Assessment Partnership (CATNAPTM)
CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed.
The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Director Clinical Trial Disclosure & Transparency
- Phone Number: 2158709177
- Email: ClinicalTrialDisclosure@JazzPharma.com
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85016
- Not yet recruiting
- Phoenix Children's Hospital
-
Tucson, Arizona, United States, 85719
- Recruiting
- University of Arizona
-
-
Arkansas
-
Fayetteville, Arkansas, United States, 72701
- Not yet recruiting
- University of Arkansas
-
Little Rock, Arkansas, United States, 72202
- Recruiting
- Arkansas Children's Research Institute
-
-
California
-
Redwood City, California, United States, 94063
- Recruiting
- Stanford University
-
San Diego, California, United States, 92093
- Recruiting
- University Of California San Diego
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Not yet recruiting
- Children's National Medical Center
-
Washington, District of Columbia, United States, 20010
- Not yet recruiting
- Children's Research Institute
-
-
Florida
-
Tampa, Florida, United States, 33620
- Recruiting
- University of South Florida
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Not yet recruiting
- Lurie Children's Hospital of Chicago
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Not yet recruiting
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital
-
-
Michigan
-
Grand Rapids, Michigan, United States, 49503
- Not yet recruiting
- Trinity Health-Michigan
-
Rochester, Michigan, United States, 55905
- Not yet recruiting
- Mayo Clinic
-
-
Missouri
-
Chesterfield, Missouri, United States, 63017
- Recruiting
- St. Luke's Hospital
-
Kansas City, Missouri, United States, 64108
- Recruiting
- Children's Mercy Hospital
-
-
New York
-
Manhasset, New York, United States, 11030
- Recruiting
- Northwell Health
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Recruiting
- Cincinnati Children's Hospital Medical Center
-
Cleveland, Ohio, United States, 44106
- Recruiting
- University Hospitals Cleveland Medical Centre (UHCMC)
-
Columbus, Ohio, United States, 43205
- Not yet recruiting
- Nationwide Children's Hospital
-
Dublin, Ohio, United States, 43017
- Recruiting
- Ohio Sleep Medicine Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Recruiting
- Geisinger
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- Children's Hospital of Philadelphia
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- Texas Children's Hospital (Baylor College of Medicine)
-
-
Virginia
-
Norfolk, Virginia, United States, 23507
- Recruiting
- Children's Hospital of The King's Daughters
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
- Age less than 18 years
- Willing to participate in the Registry and complete the informed consent form
- Able to participate in English based registry
Exclusion Criteria:
- Age 18 years or more
- Fail to complete the informed consent form
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improve Understanding of Natural History of Pediatric Narcolepsy
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Characterize the Presentation, Identification, and Diagnosis of Narcolepsy in Pediatric Participants
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Understand Treatment Practices and Outcomes Captured by Treatment Regimen and Rational for Changes
Time Frame: Up to 4 years
|
Up to 4 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improvements in Quality of Life (QoL) as Measured by Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) Questionnaire
Time Frame: Up to 4 years
|
Up to 4 years
|
|
QoL - Pediatric Quality of Life Inventory (PedsQL)
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Change in frequency of child ehavioral problems utilizing the Child Behavior Checklist (CBCL)
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Patient Reported Outcomes Measurement Information System (PROMIS) Peer Relationship-Parent Proxy Short Form v2.0
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Caregiver Work Limitations Questionnaire (C-WLQ)
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Work Productivity and Activity Impairment (WPAI)
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Change in Caregiver Well-being Measured by the Caregiver Well-Being Scale (Shortened)
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Change in Level of Social Support using the Social Support Survey Instrument
Time Frame: Up to 4 years
|
Up to 4 years
|
|
Change in Pittsburgh Sleep Quality index (PSQI) scores
Time Frame: Up to 4 years
|
Up to 4 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HealhieCATNAPN.A.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Narcolepsy
-
TakedaRecruitingNarcolepsy Type 1 | Narcolepsy Type 2Spain
-
University of Dublin, Trinity CollegeSt. James's Hospital, IrelandSuspendedNarcolepsy | Hypersomnolence | Narcolepsy Type 1 | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy | Narcolepsy 1 | Narcolepsy and HypersomniaIreland
-
Northwestern UniversityCompletedNarcolepsy | Narcolepsy Type 1 | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy | Narcolepsy Type 2United States
-
TakedaRecruitingNarcolepsy With Cataplexy | Narcolepsy Type 1 (NT1)United States, France, Germany, Netherlands, Switzerland
-
Vertex Pharmaceuticals IncorporatedNot yet recruitingNarcolepsy Type 1 (NT1)
-
University of UtahNot yet recruitingNightmare | Narcolepsy | Narcolepsy Type 1 | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy | Nightmare Disorder With Associated Other Sleep DisorderUnited States
-
Centessa Pharmaceuticals (UK) LimitedRecruitingNarcolepsy Type 1 | Narcolepsy Type 2United States
-
NLS PharmaceuticsCompletedNarcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With CataplexyUnited States
-
NLS PharmaceuticsNot yet recruitingNarcolepsy Type 1 | Narcolepsy With Cataplexy
-
BioprojetCompletedNarcolepsy Without Cataplexy | Narcolepsy With CataplexyFrance, Italy, Russian Federation, Finland, Netherlands